ERS 2023 Insights
Videos
ERS 2023 Insights
ERS 2023 Insights: Sarcoidosis - When Is HRCT Not Enough and When Should PCCT Be Performed?
FEATURING
Adam Domonkos Tarnoki
- 502 views
- October 11, 2023
- 3
ERS 2023 Insights
ERS 2023 Insights: Novel Immune Mechanisms of COPD Initiation and Progression
FEATURING
Francesca Polverino
- 565 views
- October 10, 2023
- 4
ERS 2023 Insights
ERS 2023 Insights: Pharmacological Treatment and Current Controversies in COPD
FEATURING
Konstantinos Kostikas
- 1,256 views
- October 5, 2023
- 15
ERS 2023 Insights
ERS 2023 Insights: Novel Methods of Symptom Monitoring and Management in Interstitial Lung Disease
FEATURING
Kerri Ilene Aronson
- 617 views
- October 4, 2023
- 2
ERS 2023 Insights
ERS 2023 Insights: Are Approved PAH Drugs Disease-Modifying?
FEATURING
Olivier Sitbon
- 271 views
- October 4, 2023
- 2
ERS 2023 Insights
ERS 2023 Insights: Post Hoc Analyses of Senolytic Pilot Trials in Idiopathic Pulmonary Fibrosis
FEATURING
Dean Kellogg
- 276 views
- September 28, 2023
ERS 2023 Insights
ERS 2023 Insights: A Long-Term Follow-Up Study of Sotatercept for Pulmonary Arterial Hypertension
FEATURING
Ioana Preston
- 278 views
- September 27, 2023
- 1
ERS 2023 Insights
ERS 2023 Insights: Different Thrombus Recanalization Strategies in Patients With Intermediate-High Risk or High-Risk PE
FEATURING
David Jimenez
- 304 views
- September 26, 2023
- 4
ERS 2023 Insights
ERS 2023 Insights: Obstructive Sleep Apnea and Pulmonary Embolism - What Do We Know and What Do We Need to Know
FEATURING
Alberto Ortega
- 579 views
- September 26, 2023
- 2
ERS 2023 Insights
ERS 2023 Insights: Defining Disease Modification in PAH
FEATURING
Sandeep Sahay
- 463 views
- September 19, 2023
- 4
ERS 2023 Insights
ERS 2023 Insights: Management of Dyspnea in ILD
FEATURING
Yet Khor
- 470 views
- September 19, 2023
- 6
ERS 2023 Insights
ERS 2023 Insights: Should β-Blockers Be Used in Patients With Chronic Obstructive Pulmonary Disease?
FEATURING
Alan Kaplan
- 856 views
- September 18, 2023
- 5
ERS 2023 Insights
ERS 2023 Insights: Evolution in GOLD - We Cannot "See" "C" Anymore and LABA/ICS Are Gone. Helpful or a Hindrance?
FEATURING
Antonio Anzueto
- 1,382 views
- September 11, 2023
- 9